Adage Capital Partners’s ESSA Pharma EPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,474,165
Closed -$8.93M 902
2024
Q3
$8.93M Hold
1,474,165
0.02% 630
2024
Q2
$7.75M Sell
1,474,165
-106,210
-7% -$675K 0.01% 648
2024
Q1
$13.4M Buy
1,580,375
+444,444
+39% +$3.88M 0.03% 545
2023
Q4
$7.5M Buy
1,135,931
+93,400
+9% +$460K 0.02% 639
2023
Q3
$3.22M Hold
1,042,531
0.01% 709
2023
Q2
$2.81M Hold
1,042,531
0.01% 723
2023
Q1
$3.1M Hold
1,042,531
0.01% 747
2022
Q4
$2.63M Hold
1,042,531
0.01% 797
2022
Q3
$1.9M Hold
1,042,531
﹤0.01% 857
2022
Q2
$3.28M Sell
1,042,531
-500,000
-32% -$2.79M 0.01% 846
2022
Q1
$9.53M Hold
1,542,531
0.02% 710
2021
Q4
$21.9M Hold
1,542,531
0.04% 431
2021
Q3
$12.3M Buy
1,542,531
+192,531
+14% +$3.06M 0.02% 633
2021
Q2
$38.6M Hold
1,350,000
0.08% 272
2021
Q1
$39.2M Buy
+1,350,000
New +$31.4M 0.08% 262

Other funds holding EPIX